DNA Shed by Colon Cancers May Help Oncologists Personalize Postsurgical Treatment | Naviance

DNA Shed by Colon Cancers May Help Oncologists Personalize Postsurgical Treatment

DNA Shed by Colon Cancers May Help Oncologists Personalize Postsurgical Treatment

A new international study co-led by Johns Hopkins researchers shows that measuring circulating tumor DNA (ctDNA) can help personalize treatment for patients with Stage 3 colon cancer.

LEARN MORE

Recent Posts

Early Immunotherapy Shows Promising Results in Advanced Basal Cell Carcinoma New NIH-Funded Johns Hopkins Medicine Study Finds High-Risk Individuals Who Have Mild Dilatation of the Pancreatic Duct Have Increased Risk for Pancreatic Cancer Lung Cancer Symptoms Doctors Say Women Should Never Ignore and the Screening Most Skip Targeted Radiation During Surgery Reduces Pancreatic Cancer Recurrence Colorectal Cancer Is Becoming More Common In Young People. Here Are The Signs. Johns Hopkins-Led Study Finds Drugs Approved for Treating Pain Also Reduce Bone Cancer Growth Cancer treatments based on our internal clock could improve outcomes First-Ever Clinical Trial Demonstrates Safety, Molecular Readout and Promise of Pre- and Post-Surgery Immunotherapy Combination for Patients with Operable Mesothelioma Treatment Resistance in Prostate Cancer